Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)
9,800.00
0.00 (0.00%)
At close: Aug 12, 2025
HNX:MKV Revenue
Cai Lay Veterinary Pharmaceutical JSC had revenue of 33.83B VND in the quarter ending June 30, 2025, with 32.52% growth. This brings the company's revenue in the last twelve months to 122.75B, up 10.68% year-over-year. In the year 2024, Cai Lay Veterinary Pharmaceutical JSC had annual revenue of 107.04B, down -3.49%.
Revenue (ttm)
122.75B
Revenue Growth
+10.68%
P/S Ratio
0.40
Revenue / Employee
1.18B
Employees
104
Market Cap
49.00B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 107.04B | -3.87B | -3.49% |
Dec 31, 2023 | 110.91B | -8.73B | -7.30% |
Dec 31, 2022 | 119.63B | 17.22B | 16.82% |
Dec 31, 2019 | 102.41B | -32.17B | -23.90% |
Dec 31, 2018 | 134.58B | 101.66B | 308.87% |
Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 1, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition